Science you can verify
Developed from scientific research, our quantitative QTests are validated against laboratory reference methods and used by researchers, drug-checking services and individuals worldwide.
Explore the Evidence ↓
Why Trust Miraculix
Our Trusted Partners
Meet the Scientists Behind Miraculix
Born from research at Friedrich Schiller University Jena, Miraculix brings together highly qualified scientists, including PhD researchers, and specialists in analytical testing, drug checking and photometry. Our team combines academic expertise with hands-on experience to develop reliable testing solutions and make substance analysis more accessible.
Dr. Felix Blei
Founder & CEO | PhD in Microbiology
A pioneering researcher in psilocybin biosynthesis and natural products, Felix contributed to the discovery of the psilocybin biosynthetic pathway in Psilocybe mushrooms. As the founder and scientific driving force behind Miraculix, he transformed groundbreaking university research into innovative quantitative QTests. Today, as CEO, he leads Miraculix's strategic direction, driving scientific innovation, technological advancement and the expansion of accessible drug-checking solutions.
Dr. Marina García Moreno
Chief Scientific Officer (CSO) | PhD in Microbiology
With a PhD in Microbiology, Marina combines scientific leadership with hands-on expertise in analytical testing, drug checking and product development. As CSO, she plays a key role in advancing Miraculix's scientific innovation, contributing to the development, optimization and validation of QTests and photometric methods. She is also actively involved in real-world substance analysis and scientific communication, bridging laboratory research with accessible, evidence-based harm reduction.
Dr. André Then
Chief Data Officer (CDO) | PhD in Bioinformatics
With a PhD in Bioinformatics and extensive experience in data science, André specializes in combining analytical chemistry with data-driven technologies. At Miraculix, he contributes his expertise in photometric analysis, data processing and digital solutions, transforming analytical measurements into meaningful, accessible insights. His work helps bridge laboratory science with innovative technologies that make substance analysis more efficient and accessible.
Sebastian Dörner
Drug Checking & Substance Analysis | PhD Candidate in Natural Product Chemistry
Currently pursuing his PhD in Natural Product Chemistry, Sebastian combines academic research with hands-on experience in substance analysis and on-site drug checking. At Miraculix, he actively contributes to real-world drug-checking activities, bringing scientific expertise directly to the community. His work bridges laboratory research and practical harm reduction, helping make substance testing more accessible and supporting safer, informed decisions.
QTests vs. Laboratory Results
How closely do QTest results match professional laboratory analysis?
To find out, Psychedelic Passage tested psilocybin mushrooms, LSD and MDMA using Miraculix QTests and sent samples from the same batches to Energy Control International for independent laboratory analysis.
The results were closely aligned across all three samples, demonstrating the potential of QTests for accessible quantitative substance testing.
Used in Real World
Miraculix QTests are used in real-world drug checking and professional analytical settings — from state-supported harm-reduction programs to independent testing laboratories
- ALIVE Drug Checking · Thuringia
Used since 2021 in the state-supported ALIVE drug-checking program, where Miraculix provides chemical analysis alongside professional counselling by Suchthilfe in Thüringen.
Learn about ALIVE → - PPO ODYSSEE · Kiel
Miraculix QTests are used within drug-checking activities developed by PPO ODYSSEE in Schleswig-Holstein.
Learn more → - Drogenhilfe Ulm / Alb-Donau
Miraculix QTests are used within its low-threshold drug-checking service for on-site substance analysis.
Read the report → - Tryptomics · Colorado
Professional psychedelic testing laboratory partnered with Miraculix to provide QTests as an accessible option for potency testing.
Learn more →
Academic Research
Miraculix in Academic Research
Scientific chapter co-authored by Felix Blei together with researchers from Charité Berlin and the Trimbos Institute.
Peer-reviewed field study using the PSILO QTest and QTest Photometer for quantitative psilocybin analysis.
Independent scientific review referencing Miraculix as a method for determining the presence and quantity of psilocybin.
Scientific & Institutional Evidence
Validated against HPLC
QTest results are compared with laboratory reference methods during development and validation.
View validation data →
Scientifically evaluated with Charité Berlin
The ALIVE drug-checking project has been scientifically evaluated in collaboration with Charité – Universitätsmedizin Berlin.
See research →
Officially documented by the State of Thuringia
The Thuringian Ministry presents the SubCheck/ALIVE model and highlights its independent scientific evaluation by Charité Berlin.
View official source →
Validated following ICH Q2(R1) principles
Validation includes parameters such as accuracy, precision, linearity and robustness.
View validation report →
Trusted by Experts in the Field
Researchers and professionals working with psychedelics, analytical testing and harm reduction share their experience with Miraculix QTests.
Alan Rockefeller
Mycologist
“I use the Psilocybin QTest to quantify psilocybin in rare species that I study. It has given me valuable insight into their potency.”
Tryptomics
Psychedelic analytical laboratory
“Miraculix’s test is a true game-changer, making harm-reduction testing faster and more accessible than ever before.”
Sergio Pérez Rosal, MD, MSc
What our customers say
Real feedback from people using QTests at home, in research and in practice.
READ MORE REVIEWS
Featured & recognized
Miraculix and the science behind QTests have been featured, reviewed and recognized by international media and specialist publications.
VICE / High Society
Miraculix featured in international drug and harm-reduction reporting.
Science & public dialogue
Miraculix contributes to scientific, professional and policy discussions on drug checking, harm reduction and psychedelic research across Europe and internationally.
- akzept Congress — Contributions to professional discussions on drug checking and evidence-based harm reduction.
- Psychedelica Summit — Presenting research and developments in quantitative psychedelic testing.
- Nachtleben Conference Zürich — Sharing insights from real-world drug-checking practice and the ALIVE project.
- MAPS Psychedelic Science — International presence within one of the world’s largest psychedelic science conferences.
See events & appearances →
Ready to Test With Confidence?
Explore quantitative QTests built on scientific validation, independent comparison and years of real-world use.